Clinical Trial Update: The Role of Vitamin D3 in Pediatric Bronchiectasis Severity [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial evaluating the role of Vitamin D3 in pediatric bronchiectasis severity, including cystic fibrosis and non-CF bronchiectasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Cystic Fibrosis
• Non-cystic Fibrosis Bronchiectasis

Drugs mentioned

• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: Heba Omara | Conditions: Cystic Fibrosis and Non CF Bronchiectasis | Phase 2, Phase 3 | Status: COMPLETED